Antipsychotic agents: efficacy and safety in schizophrenia [PDF]
Drug, Healthcare and Patient Safety, 2012 Arão Nogueira de Araújo,1 Eduardo Pondé de Sena,1,2 Irismar Reis de Oliveira,1,3 Mario F Juruena41Postgraduation Program in Interactive Processes of Organs and Systems, 2Department of Pharmacology, Institute of Health ...
de Araújo AN +3 more
doaj +7 more sources
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. [PDF]
Front Pharmacol, 2022 Treatment of central nervous system (CNS) disorders is challenging using conventional delivery strategies and routes of administration because of the presence of the blood–brain barrier (BBB). This BBB restricts the permeation of most of the therapeutics
Pandey M +4 more
europepmc +4 more sources
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]
PLoS One, 2018 Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity.
Nehme H +6 more
europepmc +4 more sources
Antipsychotic Agents: A Clinical Update [PDF]
Mayo Clinic Proceedings, 1985 Antipsychotic agents have many indications and are frequently used. All physicians, regardless of their subspecialty, will most likely treat patients who receive these drugs. This article is designed to help nonpsychiatric physicians use antipsychotics appropriately.
John L. Black +2 more
openalex +4 more sources
Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons [PDF]
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2015 Background Data from observational studies have raised concerns about the safety of treatment with antipsychotic agents (APs) in elderly patients with dementia, but this area has been insufficiently investigated. We performed a head-to-head comparison of
Marie Sahlberg +5 more
openalex +2 more sources
Use of Second-Generation Antipsychotic Agents for Sleep and Sedation: A Provider Survey [PDF]
Sleep, 2013 OBJECTIVES Anecdotal evidence suggests that second-generation antipsychotic agents are increasingly used to treat sleep problems. This study sought to quantify the proportion of new prescriptions for second-generation antipsychotic agents started for ...
Eric D. A. Hermes +2 more
openalex +2 more sources
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study [PDF]
Annals of General Psychiatry, 2008 BackgroundTo compare the costs and effects of paliperidone extended release (ER), a new pharmaceutical treatment for the management of schizophrenia, with the most frequently prescribed oral treatments in Greece (namely risperidone, olanzapine ...
Maria Geitona +5 more
openalex +2 more sources
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Neuropsychiatric Disease and Treatment, 2009 Xinhua S Ren1,2,3, Lawrence Herz4,5, Shirley Qian1,2,3, Eric Smith3,4, Lewis E Kazis1,2,31The Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA; 2Department of ...
Xinhua S Ren +3 more
doaj +2 more sources
Association between antipsychotic agents and risk of lung cancer: a nested case-control study. [PDF]
Cancer Commun (Lond), 2022 Li J, Tang F, Si S, Xue F.
europepmc +3 more sources
Antipsychotic agent as an etiologic agent of IFIS
Journal of Cataract and Refractive Surgery, 2005 Edward Pringle, Richard Packard
+7 more sources